Goswami SK

References (7)

Title : Neuroprotective effect of herbal extracts inhibiting soluble epoxide hydrolase (sEH) and cyclooxygenase (COX) against chemotherapy-induced cognitive impairment in mice - Kulkarni_2023_Biochem.Biophys.Res.Commun_667_64
Author(s) : Kulkarni R , Mehta R , Goswami SK , Hammock BD , Morisseau C , Hwang SH , Mallappa O , Azeemuddin MM , Rafiq M , S NM
Ref : Biochemical & Biophysical Research Communications , 667 :64 , 2023
Abstract : Kulkarni_2023_Biochem.Biophys.Res.Commun_667_64
ESTHER : Kulkarni_2023_Biochem.Biophys.Res.Commun_667_64
PubMedSearch : Kulkarni_2023_Biochem.Biophys.Res.Commun_667_64
PubMedID: 37209564

Title : Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer's Disease-Like Complications of Diabetes - Pardeshi_2019_Front.Pharmacol_10_288
Author(s) : Pardeshi R , Bolshette N , Gadhave K , Arfeen M , Ahmed S , Jamwal R , Hammock BD , Lahkar M , Goswami SK
Ref : Front Pharmacol , 10 :288 , 2019
Abstract : Pardeshi_2019_Front.Pharmacol_10_288
ESTHER : Pardeshi_2019_Front.Pharmacol_10_288
PubMedSearch : Pardeshi_2019_Front.Pharmacol_10_288
PubMedID: 31068802

Title : An inhibitor of soluble epoxide hydrolase ameliorates diabetes-induced learning and memory impairment in rats - Minaz_2018_Prostaglandins.Other.Lipid.Mediat_136_84
Author(s) : Minaz N , Razdan R , Hammock BD , Goswami SK
Ref : Prostaglandins Other Lipid Mediat , 136 :84 , 2018
Abstract : Minaz_2018_Prostaglandins.Other.Lipid.Mediat_136_84
ESTHER : Minaz_2018_Prostaglandins.Other.Lipid.Mediat_136_84
PubMedSearch : Minaz_2018_Prostaglandins.Other.Lipid.Mediat_136_84
PubMedID: 29751149

Title : Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats - Islam_2017_Cardiovasc.Ther_35_
Author(s) : Islam O , Patil P , Goswami SK , Razdan R , Inamdar MN , Rizwan M , Mathew J , Inceoglu B , Stephen Lee KS , Hwang SH , Hammock BD
Ref : Cardiovasc Ther , 35 : , 2017
Abstract : Islam_2017_Cardiovasc.Ther_35_
ESTHER : Islam_2017_Cardiovasc.Ther_35_
PubMedSearch : Islam_2017_Cardiovasc.Ther_35_
PubMedID: 28296232

Title : Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis - Trindade-da-Silva_2017_J.Pharmacol.Exp.Ther_361_408
Author(s) : Trindade-da-Silva CA , Bettaieb A , Napimoga MH , Lee KSS , Inceoglu B , Ueira-Vieira C , Bruun D , Goswami SK , Haj FG , Hammock BD
Ref : Journal of Pharmacology & Experimental Therapeutics , 361 :408 , 2017
Abstract : Trindade-da-Silva_2017_J.Pharmacol.Exp.Ther_361_408
ESTHER : Trindade-da-Silva_2017_J.Pharmacol.Exp.Ther_361_408
PubMedSearch : Trindade-da-Silva_2017_J.Pharmacol.Exp.Ther_361_408
PubMedID: 28356494

Title : Anti-Ulcer Efficacy of Soluble Epoxide Hydrolase Inhibitor TPPU on Diclofenac-Induced Intestinal Ulcers - Goswami_2016_J.Pharmacol.Exp.Ther_357_529
Author(s) : Goswami SK , Wan D , Yang J , Trindade da Silva CA , Morisseau C , Kodani SD , Yang GY , Inceoglu B , Hammock BD
Ref : Journal of Pharmacology & Experimental Therapeutics , 357 :529 , 2016
Abstract : Goswami_2016_J.Pharmacol.Exp.Ther_357_529
ESTHER : Goswami_2016_J.Pharmacol.Exp.Ther_357_529
PubMedSearch : Goswami_2016_J.Pharmacol.Exp.Ther_357_529
PubMedID: 26989141

Title : Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE2 induced pain model - Goswami_2015_Toxicol.Appl.Pharmacol_289_419
Author(s) : Goswami SK , Inceoglu B , Yang J , Wan D , Kodani SD , da Silva CA , Morisseau C , Hammock BD
Ref : Toxicol Appl Pharmacol , 289 :419 , 2015
Abstract : Goswami_2015_Toxicol.Appl.Pharmacol_289_419
ESTHER : Goswami_2015_Toxicol.Appl.Pharmacol_289_419
PubMedSearch : Goswami_2015_Toxicol.Appl.Pharmacol_289_419
PubMedID: 26522832